These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36144563)

  • 1. Dosimetry of [
    Orcutt KD; Henry KE; Habjan C; Palmer K; Heimann J; Cupido JM; Gottumukkala V; Cissell DD; Lyon MC; Hussein AI; Liu D; Li M; Johnson FL; Schultz MK
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma.
    Li M; Liu D; Lee D; Cheng Y; Baumhover NJ; Marks BM; Sagastume EA; Ballas ZK; Johnson FL; Morris ZS; Schultz MK
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and dosimetry of
    Dos Santos JC; Schäfer M; Bauder-Wüst U; Lehnert W; Leotta K; Morgenstern A; Kopka K; Haberkorn U; Mier W; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1081-1091. PubMed ID: 30603987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
    Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
    J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
    Tafreshi NK; Tichacek CJ; Pandya DN; Doligalski ML; Budzevich MM; Kil H; Bhatt NB; Kock ND; Messina JL; Ruiz EE; Delva NC; Weaver A; Gibbons WR; Boulware DC; Khushalani NI; El-Haddad G; Triozzi PL; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    J Nucl Med; 2019 Aug; 60(8):1124-1133. PubMed ID: 30733316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studies.
    Máthé D; Szigeti K; Hegedűs N; Horváth I; Veres DS; Kovács B; Szűcs Z
    Appl Radiat Isot; 2016 Aug; 114():1-6. PubMed ID: 27156049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
    Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.
    Li M; Liu D; Lee D; Kapoor S; Gibson-Corley KN; Quinn TP; Sagastume EA; Mott SL; Walsh SA; Acevedo MR; Johnson FL; Schultz MK
    Mol Pharm; 2019 Sep; 16(9):3904-3915. PubMed ID: 31318566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of
    Banerjee SR; Minn I; Kumar V; Josefsson A; Lisok A; Brummet M; Chen J; Kiess AP; Baidoo K; Brayton C; Mease RC; Brechbiel M; Sgouros G; Hobbs RF; Pomper MG
    J Nucl Med; 2020 Jan; 61(1):80-88. PubMed ID: 31253744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
    Hamacher KA; Sgouros G
    Med Phys; 2001 Sep; 28(9):1857-74. PubMed ID: 11585217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Chapeau D; Koustoulidou S; Handula M; Beekman S; de Ridder C; Stuurman D; de Blois E; Buchatskaya Y; van der Schilden K; de Jong M; Konijnenberg MW; Seimbille Y
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
    Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
    Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Wiseman GA; White CA; Sparks RB; Erwin WD; Podoloff DA; Lamonica D; Bartlett NL; Parker JA; Dunn WL; Spies SM; Belanger R; Witzig TE; Leigh BR
    Crit Rev Oncol Hematol; 2001; 39(1-2):181-94. PubMed ID: 11418315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice.
    Zaid NRR; Kletting P; Winter G; Prasad V; Beer AJ; Glatting G
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.
    Tafreshi NK; Silva A; Estrella VC; McCardle TW; Chen T; Jeune-Smith Y; Lloyd MC; Enkemann SA; Smalley KS; Sondak VK; Vagner J; Morse DL
    Mol Pharm; 2013 Aug; 10(8):3175-85. PubMed ID: 23763620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
    Essman SC; Lewis MR; Miller WH
    J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Methods for the Production of High-Purity
    Saini S; Bartels JL; Appiah JK; Rider JH; Baumhover N; Schultz MK; Lapi SE
    J Nucl Med; 2023 Nov; 64(11):1791-1797. PubMed ID: 37652545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.